Clearpoint Neuro, Inc. (CLPT)
12.97
-0.14
(-1.07%)
USD |
NASDAQ |
Dec 11, 16:00
13.06
+0.09
(+0.69%)
Pre-Market: 08:22
Clearpoint Neuro Research and Development Expense (Quarterly): 3.452M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 20.42M |
| Masimo Corp. | 30.50M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |
| VolitionRX Ltd. | 2.022M |